Shape Memory Medical Inc.

Shape Memory Medical Inc. is a California-based medical device company that specializes in innovative therapeutic solutions using shape memory polymer (SMP) technology. It is the first company to introduce an FDA-cleared medical device utilizing SMP technology in the vascular market. The company focuses on enhancing clinical success through smart polymer science. Shape Memory Medical's core technology, developed at Texas A&M University and Lawrence Livermore National Laboratory, allows for minimally invasive endovascular applications. Their products include the IMPEDE and IMPEDE FX Embolization Plugs, designed to block blood flow in targeted vessels, and the TrelliX Embolic Coil, which leverages SMP technology for improved performance in vascular embolization. These devices are effective in treating conditions such as aneurysms and arteriovenous malformations. Founded in 2009, Shape Memory Medical serves healthcare providers and physicians primarily in the United States and operates globally. The company has received significant funding and holds numerous patents related to SMP technology, reflecting its commitment to advancing medical treatments in the vascular field.

• Employees 46
• Founded 2009
• Annual Revenue $7666000
• Total Funding $66274818